Sakai Kazuya 酒井和哉

Researcher Number	60790384
Other IDs	https://orcid.org/0000-0003-0523-7931
Affiliation (Current)	2025: 奈良県立医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2024: 奈良県立医科大学, 医学部, 講師 2017 – 2020: 奈良県立医科大学, 医学部附属病院, 研究員
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related Except Principal Investigator Cardiovascular medicine
Keywords	Principal Investigator 腸内細菌叢 / ADAMTS13 / フォンヴィレブランド因子 / 血栓性血小板減少性紫斑病 / 抗血栓療法 / DNA アプタマー / 血栓止血学 / 動脈血栓症 / アプタマー / 創薬 … More / DNAアプタマー / von Willebrand因子 / 血小板凝集阻害 / von Willebrand factor / アプタマー創薬 … More Except Principal Investigator 循環器・高血圧 / Heyde症候群 / aVWS / 後天性フォンビレブランド症候群 / フォンビレブランド因子 / 血液型 / ADAMTS13 / von willebrand factor / 大動脈弁狭窄症 / VWF / 後天性フォンヴィレブランド症候群 Less

Serum Protease Activity and Gut Microbiota Modulating Thrombosis in ADAMTS13 Deficient PatientsPrincipal Investigator
- Principal Investigator
  
  酒井和哉
- Project Period (FY)
  2024 – 2025
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Nara Medical University
Inhibitory effect on platelet thrombosis formation of a novel DNA aptamer with artificial nucleic acid bases that binds to the von Willebrand factor A1 domainPrincipal Investigator
- Principal Investigator
  
  Sakai Kazuya
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Nara Medical University
Clinical analysis in pathogensisis of gastrointestinal bleeding with severe aortic stenosis according to von willebrand facor
- Principal Investigator
  
  Masaki Hayakawa
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Cardiovascular medicine
- Research Institution
  Nara Medical University

All 2019

All Journal Article

[Journal Article] Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and H.2019
- Author(s)
  Hayakawa M, Kato S, Matsui T, Sakai K, Fujimura Y, Matsumoto M
- Journal Title
  
  Journal of thrombosis and haemostasis : JTH
  
  Volume: 17/ 6 Pages: 975-983
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09518
[Journal Article] Blood group antigen A on von Willebrand factor is more protective against ADAMTS 13 cleavage than antigens B and H2019
- Author(s)
  Hayakawa Masaki、Kato Seiji、Matsui Taei、Sakai Kazuya、Fujimura Yoshihiro、Matsumoto Masanori
- Journal Title
  
  Journal of Thrombosis and Haemostasis
  
  Volume: in press Issue: 6 Pages: 975-983
- DOI
  10.1111/jth.14444
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09518
[Journal Article] Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab2019
- Author(s)
  Sakai Kazuya、Someya Tatsuhiko、Harada Kaori、Yagi Hideo、Matsui Taei、Matsumoto Masanori
- Journal Title
  
  Haematologica
  
  Volume: - Issue: 11 Pages: 2631-2638
- DOI
  10.3324/haematol.2019.235549
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17838

1. Masaki Hayakawa (30516729)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
2. 松本雅則 (60316081)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results

Sakai Kazuya 酒井和哉

Research Projects

Research Products

Co-Researchers

Serum Protease Activity and Gut Microbiota Modulating Thrombosis in ADAMTS13 Deficient PatientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Inhibitory effect on platelet thrombosis formation of a novel DNA aptamer with artificial nucleic acid bases that binds to the von Willebrand factor A1 domainPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Clinical analysis in pathogensisis of gastrointestinal bleeding with severe aortic stenosis according to von willebrand facor

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and H.2019

Author(s)

Journal Title

Data Source

[Journal Article] Blood group antigen A on von Willebrand factor is more protective against ADAMTS 13 cleavage than antigens B and H2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab2019

Author(s)

Journal Title

DOI

Data Source

Sakai Kazuya 酒井 和哉

Research Projects

Research Products

Co-Researchers

Serum Protease Activity and Gut Microbiota Modulating Thrombosis in ADAMTS13 Deficient PatientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Inhibitory effect on platelet thrombosis formation of a novel DNA aptamer with artificial nucleic acid bases that binds to the von Willebrand factor A1 domainPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Clinical analysis in pathogensisis of gastrointestinal bleeding with severe aortic stenosis according to von willebrand facor

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and H.2019

Author(s)

Journal Title

Data Source

[Journal Article] Blood group antigen A on von Willebrand factor is more protective against ADAMTS 13 cleavage than antigens B and H2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab2019

Author(s)

Journal Title

DOI

Data Source

Sakai Kazuya 酒井和哉